1. Home
  2. BBGI vs BCDA Comparison

BBGI vs BCDA Comparison

Compare BBGI & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

HOLD

Current Price

$3.33

Market Cap

10.5M

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$1.17

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBGI
BCDA
Founded
1961
N/A
Country
United States
United States
Employees
N/A
21
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
12.5M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
BBGI
BCDA
Price
$3.33
$1.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
12.8K
64.3K
Earning Date
05-06-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$232,179,463.00
N/A
Revenue This Year
$5.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
69.89
N/A
52 Week Low
$3.26
$1.00
52 Week High
$26.37
$3.20

Technical Indicators

Market Signals
Indicator
BBGI
BCDA
Relative Strength Index (RSI) 33.77 40.90
Support Level $3.26 $1.13
Resistance Level $4.67 $1.39
Average True Range (ATR) 0.31 0.08
MACD -0.00 -0.01
Stochastic Oscillator 1.27 13.76

Price Performance

Historical Comparison
BBGI
BCDA

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: